Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07787650 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)

StatusNot Yet Recruiting
PhasePhase 1
SponsorShionogi
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Shionogi
45 trials monitored
See 2 trials at risk
The primary purpose of this study is to evaluate the safety and tolerability profile of S-606001 in participants with LOPD.
Trial Details
NCT Number NCT07787650
Lead Sponsor Shionogi
Conditions
(from sponsor)		 Pompe Disease
Related terms Glycogen Storage Disease, Glycogen Storage Disease Type II, Rare Diseases
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov